Concepedia

Chen‐Ying Liu

CL

38

Publications

3.6K

Citations

27

H-Index

2009

Active since

Affiliations

XinHua Hospital(Current)

Shanghai Jiao Tong University

Fudan University

Shanghai Cancer Institute

Zhongshan Hospital

Chen‐Ying Liu is an author at XinHua Hospital specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCell SignalingCancer ResearchColorectal CancerPathologyCancer BiologySignal TransductionTranscriptional Regulation

Publications per year

2009–2025

38

Publications

38

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

Bin Zhao, Li Li, Q. Richard Lu et al. · Genes & Development · 2011 · 657 citations · Full text

Hippo Pathway, Signal Transduction, Yap Oncoprotein +14

TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

Heng Zhang, Chen‐Ying Liu, Zhengyu Zha et al. · Journal of Biological Chemistry · 2009 · 565 citations · Full text

Epithelial-mesenchymal Transition, Transcriptional Regulation, Signal Transduction +11

The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase

Chen‐Ying Liu, Zhengyu Zha, Xin Zhou et al. · Journal of Biological Chemistry · 2010 · 507 citations · Full text

Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis

Zhen Wei, Jinglue Song, Guanghui Wang et al. · Nature Communications · 2018 · 189 citations · Full text

The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition

Wei Huang, Xianbo Lv, Chen‐Ying Liu et al. · Journal of Biological Chemistry · 2012 · 159 citations · Full text

Rows per page

1–5 of 38